EUVIMEDEUVIMED entdecken
Open Access

Does Missing Medication Acutely Change Seizure Risk? A Prospective Study

Daniel M Goldenholz iD, Joshua C Cheng, Chi-Yuan Chang iD, Robert Moss, M Brandon Westover

Annals of Neurology · 2026

DOI: 10.1002/ana.78134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2026. Verfasst von Daniel M Goldenholz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Anticonvulsants, Seizures, Drug Resistant Epilepsy, Medication Adherence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study was to determine whether missing individual doses of anti‐seizure medications (ASMs) elevate short‐term seizure risk in people with drug‐resistant epilepsy.

Methods

In a prospective, community‐based cohort, adults with drug‐resistant epilepsy (≥ 3 seizures/month) or their caregivers recorded seizures and ASM intake with smartphone applications for 10 months each. Individual level analysis modeled the relationships between ASM adherence with seizure occurrence, as well as with a simplified seizure forecast via a 90‐day moving average (“Napkin method”). Group‐level analysis with a mixed‐effects model was performed to examine the relationship between ASM adherence and simplified forecasts, while controlling for differences in individual seizure frequency via random effects.

Results

Twenty‐seven participants (median age = 29 years) contributed 7,853 person‐days. Individual analysis showed that only a small (n = 2) number of participants had a weak relationship between ASM adherence with seizure occurrence. Group‐level analysis showed that seizure occurrence was highly linked to the Napkin method, but not ASM adherence.

Interpretation

Among individuals with frequent, drug‐resistant epilepsy, occasional missed ASM doses did not measurably raise immediate seizure risk. Whereas sustained nonadherence remains a clinical concern, clinicians may reassure patients that infrequent brief lapses are unlikely to trigger seizures acutely, yet they should continue emphasizing overall adherence for long‐term seizure control. ANN NEUROL 2026;99:1076–1082

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsSeizuresDrug Resistant EpilepsyMedication AdherenceHumansMaleFemaleAdultProspective StudiesMiddle AgedYoung Adult

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Department of Neurology, Harvard Medical School, Boston, MA.
  • Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA.
  • Seizure Tracker LLC, Springfield, VA.

ORCID-Profile: Daniel M Goldenholz, Chi-Yuan Chang

Förderung

  • NIH HHS
  • NIA NIH HHS
  • NINDS NIH HHS
  • NHLBI NIH HHS
  • National Science Foundation
  • National Institutes of Health

Zitieren

APA

Goldenholz, D. M., Cheng, J. C., Chang, C. Y., Moss, R., & Westover, M. B. (2026). Does Missing Medication Acutely Change Seizure Risk? A Prospective Study. Annals of Neurology. https://doi.org/10.1002/ana.78134

Vancouver

Goldenholz DM, Cheng JC, Chang CY, Moss R, Westover MB. Does Missing Medication Acutely Change Seizure Risk? A Prospective Study. Annals of Neurology. 2026. doi:10.1002/ana.78134

BibTeX
@article{Goldenholz2026,
  author = {Goldenholz, Daniel M and Cheng, Joshua C and Chang, Chi-Yuan and Moss, Robert and Westover, M Brandon},
  title = {Does Missing Medication Acutely Change Seizure Risk? A Prospective Study},
  journal = {Annals of Neurology},
  year = {2026},
  doi = {10.1002/ana.78134}
}
Kostenlos starten →